Preclinical and clinical studies have demonstrated that DFMO can effectively inhibit ODC, the key enzyme in polyamine biosynthesis, leading to decreased tumor growth and improved survival in animal models and human patients. The gene discussed is ODC1; the disease is neoplasm.